Published in Br J Clin Pharmacol on January 01, 2010
The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients. Br J Clin Pharmacol (2016) 0.82
Therapeutic drug monitoring in pediatric renal transplantation. Pediatr Nephrol (2014) 0.78
Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid. Eur J Clin Pharmacol (2012) 0.78
Expression of IMPDH mRNA after mycophenolate administration in male volunteers. Biomed Res Int (2014) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl (1968) 2.79
Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol (2003) 1.89
Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation. Am J Transplant (2004) 1.77
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant (2007) 1.76
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit (2001) 1.53
Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem (1990) 1.43
Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters. J Biol Chem (1997) 1.42
Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf (2001) 1.39
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant (2003) 1.31
Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit (2006) 1.30
Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats. J Pharmacol Exp Ther (2004) 1.19
Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs. J Biol Chem (1988) 1.18
Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells. Ther Drug Monit (2009) 1.11
Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem (1995) 1.11
Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transplant Proc (1996) 1.05
Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity? Transplant Proc (2007) 1.04
Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells. Clin Biochem (2001) 1.03
The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation. Transplantation (2005) 1.03
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene. J Clin Invest (2000) 1.01
Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem (1998) 0.98
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients. Am J Transplant (2007) 0.96
Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene. J Biol Chem (1995) 0.93
The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant (2003) 0.92
Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem (2002) 0.92
Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation. Clin Pharmacol Ther (2007) 0.88
Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression. Transplantation (2008) 0.86
Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil. Clin Pharmacol Ther (1999) 0.85
Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy. Ther Drug Monit (2004) 0.84
Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Clin Pharmacol Ther (2001) 0.83
Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.82
Therapeutic drug monitoring of mycophenolic acid. Clin J Am Soc Nephrol (2007) 0.82
Pharmacodynamic monitoring of mycophenolate mofetil. Clin Chem Lab Med (2000) 0.81
Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation. Transplant Proc (2006) 0.80
Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment. Scand J Clin Lab Invest (2006) 0.80
Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients. Clin Sci (Lond) (2004) 0.78
Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology. Clin Chim Acta (2007) 0.77
Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5'-monophosphate dehydrogenase in whole blood and isolated mononuclear cells. Ther Drug Monit (2000) 0.77
Pharmacodynamics in the development of new immunosuppressive drugs. Ther Drug Monit (2004) 0.76
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology (2008) 8.24
Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Chest (2010) 2.92
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood (2007) 2.41
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection. J Hepatol (2013) 2.19
Image in clinical medicine. Hypercarotenemia. N Engl J Med (2002) 2.03
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology (2012) 1.97
Rapid on-site evaluation of transbronchial aspirates in the diagnosis of hilar and mediastinal adenopathy: a randomized trial. Chest (2010) 1.89
Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol (2012) 1.83
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica (2002) 1.72
Transbronchial needle aspiration in sarcoidosis: yield and predictors of a positive aspirate. J Thorac Cardiovasc Surg (2008) 1.64
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract (2011) 1.61
Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study. Nephrol Dial Transplant (2012) 1.51
Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int (2005) 1.44
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant (2007) 1.43
Severe symptomatic hyponatremia during sibutramine therapy: a case report. Am J Kidney Dis (2008) 1.39
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program. J Acquir Immune Defic Syndr (2007) 1.38
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. J Clin Oncol (2006) 1.30
Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol (2005) 1.28
Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol (2009) 1.28
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium (2006) 1.27
Reproducibility of real-time shear wave elastography in the evaluation of liver elasticity. Eur J Radiol (2012) 1.24
Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. Curr HIV Res (2007) 1.23
Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology (2010) 1.21
Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations. J Cardiovasc Med (Hagerstown) (2009) 1.16
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Haematologica (2008) 1.16
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients. J Infect Dis (2003) 1.13
Port-access minimally invasive surgery for atrial septal defects: a 10-year single-center experience in 166 patients. J Thorac Cardiovasc Surg (2009) 1.10
Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol (2005) 1.07
Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion (2010) 1.06
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels (2007) 1.05
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma. J Med Virol (2008) 1.05
Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem (2011) 1.04
Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation. Clin Cancer Res (2010) 1.04
Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol (2006) 1.04
Helicobacter pyloril-asparaginase: a promising chemotherapeutic agent. Biochem Biophys Res Commun (2008) 1.04
Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics (2003) 1.04
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. PLoS One (2010) 1.04
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs. Antivir Ther (2005) 1.04
Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haematol (2005) 1.03
Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study. Worldviews Evid Based Nurs (2012) 1.02
Renal function and functional reserve in healthy elderly individuals. J Nephrol (2007) 1.02
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial. J Acquir Immune Defic Syndr (2003) 1.01
Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol (2008) 1.01
Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping. Chest (2015) 1.00
The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J Glaucoma (2003) 1.00
SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clin Chem (2008) 1.00
Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients. Eur J Clin Pharmacol (2005) 0.99
Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine. AIDS (2010) 0.99
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. BMC Infect Dis (2005) 0.99
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. J Antimicrob Chemother (2010) 0.99
An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry (2009) 0.98
How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments. Curr Drug Metab (2010) 0.98
Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis (2013) 0.97
Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int (2008) 0.97
Performance of real-time strain elastography, transient elastography, and aspartate-to-platelet ratio index in the assessment of fibrosis in chronic hepatitis C. AJR Am J Roentgenol (2012) 0.96
Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol J (2011) 0.96
Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrob Agents Chemother (2012) 0.95
Pyruvate kinase deficiency: the genotype-phenotype association. Blood Rev (2007) 0.95
Hyoidthyroidpexia as a treatment in multilevel surgery for obstructive sleep apnea. Acta Otolaryngol (2008) 0.94
Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol Aging (2006) 0.93
CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis. AIDS Rev (2008) 0.93
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study. Diabetes Technol Ther (2009) 0.93
CD4+ cell-count-guided treatment interruptions in chronic HIV-infected patients with good response to highly active antiretroviral therapy. AIDS (2004) 0.93
Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3. Curr HIV Res (2010) 0.93
Ultrasound point shear wave elastography assessment of liver and spleen stiffness: effect of training on repeatability of measurements. Eur Radiol (2014) 0.93
Expanding targets for a metabolic therapy of cancer: L-asparaginase. Recent Pat Anticancer Drug Discov (2012) 0.92
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study. HIV Clin Trials (2002) 0.92
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey. BJU Int (2012) 0.92
Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney Int (2004) 0.92
Performance characteristics and predictors of yield from transbronchial needle aspiration in the diagnosis of peripheral pulmonary lesions. Respirology (2011) 0.91
Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation. J Clin Microbiol (2008) 0.91
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration. Ann Pharmacother (2010) 0.91
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. Nephrol Dial Transplant (2013) 0.90
Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens. Ther Drug Monit (2008) 0.90
A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents. Helicobacter (2002) 0.90
Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients. Antivir Ther (2002) 0.90
Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain. Eur J Clin Pharmacol (2013) 0.89
Multilevel examination of minor salivary gland biopsy for Sjogren's syndrome significantly improves diagnostic performance of AECG classification criteria. Arthritis Res Ther (2005) 0.89
Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy. Antivir Ther (2005) 0.89
Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene. Br J Haematol (2005) 0.89
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract (2005) 0.89
Prevention of dialysis hypotension episodes using fuzzy logic control system. Nephrol Dial Transplant (2007) 0.89
Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations. Respirology (2014) 0.89
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort. J Antimicrob Chemother (2005) 0.88
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol (2013) 0.88
KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells. Growth Factors (2007) 0.88
The value of flexible transbronchial needle aspiration in the diagnosis of stage I sarcoidosis. Chest (2003) 0.87
Growth hormone deficiency and coeliac disease: an unusual association? Clin Endocrinol (Oxf) (2005) 0.87
Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol (2002) 0.87
Return to work after thoracic organ transplantation in a clinically-stable population. Eur J Heart Fail (2007) 0.86
Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency. PLoS One (2012) 0.86
Effects of structured treatment interruptions on metabolic, anthropometric, immunologic, and quality of life outcomes in HIV-positive adults on HAART. Curr HIV Res (2007) 0.86
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. PLoS One (2011) 0.86
Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur J Endocrinol (2005) 0.86